Hematology and Cancer Research Leader
ae
Khaled Musallam is a Hematology and Cancer Research Leader, ranked #3 in Health & Medicine (Oncology & Cancer) (Top 50%).
Last updated
Khaled Musallam is a prominent medical professional specializing in hematology and cancer research. He serves as the Group Chief Research Officer at Burjeel Holdings and Deputy CEO at Burjeel Cancer Institute. His work focuses on advancing hematology services, cell and gene therapies, and clinical trials. Musallam frequently publishes in high-impact journals, collaborates internationally, and participates in academic conferences. He is also an adjunct professor at Khalifa University and Weill Cornell Medicine, contributing to medical education and research in the UAE and globally.
Advancing science in uncertain times is an assertion of collective endurance.
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.
United Arab Emirates
